Pliant Therapeutics is a public, clinical stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic thought leaders, Pliant is raising the bar to meet the unmet medical needs of physicians, patients and families impacted by fibrotic disease. The Company’s focus is on mechanism-based intervention in the fibrotic process using small molecules.

The Company’s lead product candidate, PLN-74809, is an oral, small molecule selective inhibitor of the αvβ1 and αvβ6 integrins that play a key role in multiple fibrotic pathways. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration in both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC) and are currently in Phase 2a clinical trials for these indications. The company recently reported positive data from its Phase 2a trial in IPF and is currently ramping up activities in preparation for a late-stage clinical trial at worldwide sites.

Pliant has also developed PLN-1474, a small molecule, selective inhibitor of αvß1 for the treatment of nonalcoholic steatohepatitis, or NASH with liver fibrosis. Pliant is initiating a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company also has discovery and development programs in oncology and muscular dystrophies.

The Company is seeking passionate, creative, and dedicated individuals to join our team and contribute to our mission.



The Associate Director, Biostatistics is a critical member of the statistical team, who provides study level statistical support in cross-functional settings including participating in study design, sample size calculations, supervision of CRO, reviewing statistical analysis plan, TFL shells, CRF, DSMB charter, TFL outputs, abstracts, CSR, IND, ISS, ISE, managing study timelines. Some hands-on ad-hoc analyses may be required outside of the CRO provided outputs.



  • Responsible for statistical input to clinical development plans, clinical study concepts and protocols, case report forms, clinical study reports, regulatory documents, scientific publications, internal and external meetings, and presentations.
  • Accountable for development, implementation and execution of statistical analysis plans that support clinical development plans and clinical protocols, to ensure statistical integrity, adequacy and accuracy.
  • Accountable for production of biostatistics deliverables (planned, post-hoc, and/or exploratory analyses) by providing oversight of the work performed by CROs, managing external Biostatistics and Statistical Programming consultants, as needed, or performing the work themselves, to ensure timeliness and quality of analysis data and statistical outputs.
  • Contribute to developing Departmental standards (CRF design, ADaM datasets, TFL Mocks).
  • Responsible for development and interpretation of topline study results in close collaboration with the clinical and cross-functional teams.
  • Participate in global regulatory interactions including filings, written, oral and face to face interactions, as needed.
  • Lead one or more department initiatives.
  • Ensure all biostatistics activities comply with industry norms, health authority regulations, ICH/GCP guidelines and company SOPs.




To perform this job successfully, an individual must be able to perform each essential duty. The requirements listed below are representative of the knowledge, skill, abilities and prior experience required.

  • PhD or MS in statistics or mathematics.
  • At least 5-7 years of pharma / biotech industry experience. Rare disease or Oncology experience is a plus.
  • Comprehensive knowledge of clinical trials methodology, and statistical software packages. Proficiency in SAS required, and knowledge of other languages (R) is a plus.
  • Comprehensive knowledge of FDA/EMA/ICH guidelines for statistical and clinical data analysis, data structure, and new developments and industry standards in statistics and drug development.
  • Proven experience within both early and late-stage development phases, including selection of relevant clinical study endpoints and outcome measures.
  • Preferred experience managing external statistical and programming resources.
  • Proven track record of innovative approaches such as adaptive clinical trial design.
  • Excellent interpretation and presentation skills and ability to communicate statistical concepts and data to non-statisticians.
  • Advanced knowledge of CDISC requirements for SDTM and ADaM.
  • Knowledge of clinical data management systems.
  • Able to collaborate effectively with internal, cross-functional, and external study teams to meet project timelines.
  • Excellent organizational skills and attention to detail. 
  • Able to set priorities and juggle multiple projects and demands.
  • Able to work independently while exercising initiative, flexibility, and sound judgment.
  • Ability to operate in alignment with Pliant’s values.


Pliant requires all new hires to be fully vaccinated prior to the first date of employment (subject to any legally required exemptions).


The annual base salary for this role is $170,000 - $200,000. Individual pay may vary based on additional factors, including, and without limitation job-related skills, experience, work location and relevant education or training. Pliant’s compensation package also includes benefits, equity, and annual target bonus for fulltime positions.

To understand how Pliant complies with and manages your personal information with respect to the California Consumer Privacy Act, please visit

Apply for this Job

* Required
resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Pliant Therapeutics, Inc.’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.